A 54-year-old woman is admitted to the hospital with an acute pulmonary embolism and is started on a continuous intravenous unfractionated heparin infusion. On day 5 of therapy, her platelet count drops from a baseline of to . She has no active bleeding, but she reports new-onset pain and swelling in her right lower extremity. Suspecting heparin-induced thrombocytopenia (HIT), the physician calculates a 4T score of 6 (high probability). Which of the following are the most appropriate immediate steps in the monitoring and management of this patient? (Select all that apply)
- Discontinue the unfractionated heparin infusion immediatelyAnswer
- Initiate anticoagulation with a direct thrombin inhibitorAnswer
- CTransfuse pooled platelets to reduce the risk of spontaneous hemorrhage
- DTransition the patient immediately to warfarin monotherapy
- EContinue the heparin infusion and recheck the platelet count in 24 hours
Answer
The most appropriate immediate steps are to discontinue the unfractionated heparin infusion and initiate anticoagulation with a direct thrombin inhibitor.
The correct steps for managing highly suspected heparin-induced thrombocytopenia involve simultaneously halting the offending medication and managing the resulting hypercoagulable state. Stopping all heparin immediately prevents further immune complex formation. Because the patient remains at an exceptionally high risk for thrombotic events (as evidenced by the new right lower extremity swelling), therapeutic anticoagulation must be maintained using a non-heparin agent, such as a direct thrombin inhibitor (e.g., argatroban, bivalirudin) or fondaparinux. Confirmatory testing (such as a serotonin release assay) should be ordered, but life-saving empiric treatment must not be delayed.
Step-by-Step Solution
Key Concept
Management of highly suspected heparin-induced thrombocytopenia (HIT) requires the immediate cessation of all heparin products and the concurrent initiation of a non-heparin anticoagulant.